Germline BRCA1/2 (gBRCA) mutation is found in 4–7% of PC patients, occurring more frequently than other genes associated with HRD, such as ATM, CHEK2, and PALB2 [14–19]. This evidence concerns the gene CHEK2 and hypoparathyroidism-retardation-dysmorphism syndrome.